Lonza leads market with large and HLA-typed CD34+ cell lots
Lonza now offers human cord blood CD34+ hematopoietic stem cells in large batch sizes, leading the way in addressing a critical unmet market need
Lonza now offers human cord blood CD34+ hematopoietic stem cells in large batch sizes, leading the way in addressing a critical unmet market need
Dr. Benjamin Hopkins reveals how combining transcriptomics with organoid-based drug screening could bring effective therapies to cancer patients sooner
In this on-demand webinar, Dr. Michael Bradley describes how to draw big information from tiny samples using microspectroscopy
In this on-demand webinar, Dr. Devika Kalsi, and Dr. Xin Liu illustrate how they can reduce cloning timelines from 25 to 10 weeks
HSCRB and Broad researchers use 3D, miniature models of the human brain to advance disease understanding
WuXi AppTec’s development and manufacturing platform will enable Orbit to generate peptides at small or large scale that incorporate chemical modifications to facilitate peptide optimization
Agricultural scientist, Janak Joshi, shares his future goals as a scientist and the need for clear scientific communication